{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:29:57Z","timestamp":1775939397724,"version":"3.50.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"The University of Adelaide","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advances in the treatment of cancer have significantly improved mortality rates; however, this has come at a cost, with many treatments still limited by their toxic side effects. Mucositis in both the mouth and gastrointestinal tract is common following many anti-cancer agents, manifesting as ulcerative lesions and associated symptoms throughout the alimentary tract. The pathogenesis of mucositis was first defined in 2004 by Sonis, and almost 20\u00a0years on, the model continues to be updated reflecting ongoing research initiatives and more sophisticated analytical techniques. The most recent update, published by the Multinational Association for Supportive Care in Cancer and the International Society for Oral Oncology (MASCC\/ISOO), highlights the numerous co-occurring events that underpin mucositis development. Most notably, a role for the ecosystem of microorganisms that reside throughout the alimentary tract (the oral and gut microbiota) was explored, building on initial concepts proposed by Sonis. However, many questions remain regarding the true <jats:italic>causal<\/jats:italic> contribution of the microbiota and associated metabolome. This review aims to provide an overview of this rapidly evolving area, synthesizing current evidence on the microbiota\u2019s contribution to mucositis development and progression, highlighting (i) components of the 5-phase model where the microbiome may be involved, (ii) methodological challenges that have hindered advances in this area, and (iii) opportunities for intervention.<\/jats:p>","DOI":"10.1007\/s00520-024-08752-4","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:04:15Z","timestamp":1722380655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC\/ISOO framework"],"prefix":"10.1007","volume":"32","author":[{"given":"Andrea M.","family":"Stringer","sequence":"first","affiliation":[]},{"given":"Benjamin M.","family":"Hargreaves","sequence":"additional","affiliation":[]},{"given":"Rui Amaral","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Nicole M. A.","family":"Blijlevens","sequence":"additional","affiliation":[]},{"given":"Julia S.","family":"Bruno","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Joyce","sequence":"additional","affiliation":[]},{"given":"Srinivas","family":"Kamath","sequence":"additional","affiliation":[]},{"given":"Alexa M. G. A.","family":"Laheij","sequence":"additional","affiliation":[]},{"given":"Giulia","family":"Ottaviani","sequence":"additional","affiliation":[]},{"given":"Kate R.","family":"Secombe","sequence":"additional","affiliation":[]},{"given":"Arghavan","family":"Tonkaboni","sequence":"additional","affiliation":[]},{"given":"Yehuda","family":"Zadik","sequence":"additional","affiliation":[]},{"given":"Paolo","family":"Bossi","sequence":"additional","affiliation":[]},{"given":"Hannah R.","family":"Wardill","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"issue":"7","key":"8752_CR1","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00520-013-1810-y","volume":"21","author":"N Al-Dasooqi","year":"2013","unstructured":"Al-Dasooqi N et al (2013) Emerging evidence on the pathobiology of mucositis. Support Care Cancer 21(7):2075\u20132083","journal-title":"Support Care Cancer"},{"issue":"10","key":"8752_CR2","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla RV et al (2014) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453\u20131461","journal-title":"Cancer"},{"key":"8752_CR3","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1007\/s00520-019-04892-0","volume":"27","author":"JM Bowen","year":"2019","unstructured":"Bowen JM et al (2019) Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Support Care Cancer 27:4011\u20134022","journal-title":"Support Care Cancer"},{"issue":"4","key":"8752_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc1318","volume":"4","author":"ST Sonis","year":"2004","unstructured":"Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4(4):277\u2013284","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8752_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg G et al (2020) Microbiome definition re-visited: old concepts and new challenges. Microbiome 8(1):103","journal-title":"Microbiome"},{"issue":"1","key":"8752_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K et al (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7(1):135","journal-title":"Signal Transduct Target Ther"},{"issue":"6285","key":"8752_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"T Gensollen","year":"2016","unstructured":"Gensollen T et al (2016) How colonization by microbiota in early life shapes the immune system. Science 352(6285):539\u2013544","journal-title":"Science"},{"issue":"7946","key":"8752_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-022-05620-1","volume":"614","author":"M Valles-Colomer","year":"2023","unstructured":"Valles-Colomer M et al (2023) The person-to-person transmission landscape of the gut and oral microbiomes. Nature 614(7946):125\u2013135","journal-title":"Nature"},{"issue":"1","key":"8752_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157(1):121\u2013141","journal-title":"Cell"},{"issue":"2","key":"8752_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jop.12152","volume":"44","author":"AM Stringer","year":"2015","unstructured":"Stringer AM, Logan RM (2015) The role of oral flora in the development of chemotherapy-induced oral mucositis. J Oral Pathol Med 44(2):81\u201387","journal-title":"J Oral Pathol Med"},{"issue":"23","key":"8752_CR11","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.3390\/cancers13235902","volume":"13","author":"P Gugnacki","year":"2021","unstructured":"Gugnacki P, Sierko E (2021) Is There an interplay between oral microbiome, head and neck carcinoma and radiation-induced oral mucositis? Cancers (Basel) 13(23):5902","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8752_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12866-021-02130-4","volume":"21","author":"SZ Bakhti","year":"2021","unstructured":"Bakhti SZ, Latifi-Navid S (2021) Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next? BMC Microbiol 21(1):71","journal-title":"BMC Microbiol"},{"issue":"6","key":"8752_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/annonc\/mdw053","volume":"27","author":"AA Khan","year":"2016","unstructured":"Khan AA, Khan Z, Warnakulasuriya S (2016) Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence? Ann Oncol 27(6):984\u2013997","journal-title":"Ann Oncol"},{"issue":"2","key":"8752_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbcan.2019.04.001","volume":"1871","author":"S Parida","year":"2019","unstructured":"Parida S, Sharma D (2019) The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer. Biochim Biophys Acta Rev Cancer 1871(2):392\u2013405","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"8752_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum S et al (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229\u2013241","journal-title":"Cell"},{"issue":"1","key":"8752_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/ebm.2012.012260","volume":"238","author":"DW Thorpe","year":"2013","unstructured":"Thorpe DW, Stringer AM, Gibson RJ (2013) Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Exp Biol Med (Maywood) 238(1):1\u20136","journal-title":"Exp Biol Med (Maywood)"},{"issue":"17","key":"8752_CR17","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.3390\/ijms22179474","volume":"22","author":"L Wei","year":"2021","unstructured":"Wei L, Wen XS, Xian CJ (2021) Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways. Int J Mol Sci 22(17):9474","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8752_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/SPC.0000000000000202","volume":"10","author":"E Cario","year":"2016","unstructured":"Cario E (2016) Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Curr Opin Support Palliat Care 10(2):157\u2013164","journal-title":"Curr Opin Support Palliat Care"},{"key":"8752_CR19","doi-asserted-by":"publisher","first-page":"831387","DOI":"10.3389\/fcimb.2022.831387","volume":"12","author":"L Ji","year":"2022","unstructured":"Ji L et al (2022) Roles of toll-like receptors in radiotherapy- and chemotherapy-induced oral mucositis: a concise review. Front Cell Infect Microbiol 12:831387","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"8752_CR20","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3390\/microorganisms10102048","volume":"10","author":"GH Al-Qadami","year":"2022","unstructured":"Al-Qadami GH et al (2022) Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities. Microorganisms 10(10):2048","journal-title":"Microorganisms"},{"key":"8752_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D et al (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277","journal-title":"Front Immunol"},{"issue":"1","key":"8752_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12865-022-00495-3","volume":"23","author":"X Yue","year":"2022","unstructured":"Yue X et al (2022) Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction. BMC Immunol 23(1):19","journal-title":"BMC Immunol"},{"issue":"8","key":"8752_CR23","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.4049\/jimmunol.1700105","volume":"199","author":"L Zheng","year":"2017","unstructured":"Zheng L et al (2017) Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of Claudin-2. J Immunol 199(8):2976\u20132984","journal-title":"J Immunol"},{"issue":"1","key":"8752_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1534735415610427","volume":"15","author":"A Yasueda","year":"2016","unstructured":"Yasueda A, Urushima H, Ito T (2016) Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther 15(1):17\u201339","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"8752_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00520-012-1644-z","volume":"21","author":"RJ Gibson","year":"2013","unstructured":"Gibson RJ et al (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21(1):313\u2013326","journal-title":"Support Care Cancer"},{"key":"8752_CR26","doi-asserted-by":"publisher","first-page":"1328324","DOI":"10.3389\/fmicb.2024.1328324","volume":"15","author":"Y Sun","year":"2024","unstructured":"Sun Y et al (2024) The role of gut microbiota in intestinal disease: from an oxidative stress perspective. Front Microbiol 15:1328324","journal-title":"Front Microbiol"},{"issue":"10","key":"8752_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/17425247.2023.2233900","volume":"20","author":"S Kamath","year":"2023","unstructured":"Kamath S et al (2023) Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opin Drug Deliv 20(10):1315\u20131331","journal-title":"Expert Opin Drug Deliv"},{"key":"8752_CR28","doi-asserted-by":"publisher","first-page":"710945","DOI":"10.3389\/fcimb.2021.710945","volume":"11","author":"B Yue","year":"2021","unstructured":"Yue B et al (2021) Microbiota-host-irinotecan axis: a new insight toward irinotecan chemotherapy. Front Cell Infect Microbiol 11:710945","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"8752_CR29","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1099\/mic.0.000149","volume":"161","author":"S Pedroso","year":"2015","unstructured":"Pedroso S et al (2015) Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiology (Reading) 161(10):1950\u20131960","journal-title":"Microbiology (Reading)"},{"issue":"8","key":"8752_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1124\/dmd.121.000476","volume":"49","author":"MM Parvez","year":"2021","unstructured":"Parvez MM et al (2021) Quantitative investigation of irinotecan metabolism, transport, and gut microbiome activation. Drug Metab Dispos 49(8):683\u2013693","journal-title":"Drug Metab Dispos"},{"key":"8752_CR31","first-page":"e4017","volume":"5","author":"E Vanlancker","year":"2017","unstructured":"Vanlancker E et al (2017) 5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro. PeerJ 5:e4017","journal-title":"PeerJ"},{"issue":"1","key":"8752_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00520-022-07559-5","volume":"31","author":"G Al-Qadami","year":"2023","unstructured":"Al-Qadami G et al (2023) Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study. Support Care Cancer 31(1):98","journal-title":"Support Care Cancer"},{"issue":"1","key":"8752_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12866-023-02791-3","volume":"23","author":"MS Mahdy","year":"2023","unstructured":"Mahdy MS et al (2023) Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity. BMC Microbiol 23(1):53","journal-title":"BMC Microbiol"},{"key":"8752_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cbi.2018.06.018","volume":"291","author":"P Mallick","year":"2018","unstructured":"Mallick P et al (2018) Impact of diet on irinotecan toxicity in mice. Chem Biol Interact 291:87\u201394","journal-title":"Chem Biol Interact"},{"issue":"13","key":"8752_CR35","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.1918095117","volume":"117","author":"AP Bhatt","year":"2020","unstructured":"Bhatt AP et al (2020) Targeted inhibition of gut bacterial beta-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A 117(13):7374\u20137381","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"8752_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ctim.2015.03.008","volume":"23","author":"M Mego","year":"2015","unstructured":"Mego M et al (2015) Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement Ther Med 23(3):356\u2013362","journal-title":"Complement Ther Med"},{"key":"8752_CR37","doi-asserted-by":"publisher","first-page":"100423","DOI":"10.1016\/j.cotox.2023.100423","volume":"36","author":"EKK Lo","year":"2023","unstructured":"Lo EKK et al (2023) Gut microbiota: impact on 5-fluorouracil efficacy and toxicity. Curr Opin Toxicol 36:100423","journal-title":"Curr Opin Toxicol"},{"key":"8752_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ebiom.2018.06.029","volume":"33","author":"B Zhou","year":"2018","unstructured":"Zhou B et al (2018) Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota. EBioMedicine 33:122\u2013133","journal-title":"EBioMedicine"},{"key":"8752_CR39","doi-asserted-by":"publisher","first-page":"153473542092849","DOI":"10.1177\/1534735420928493","volume":"19","author":"KR Secombe","year":"2020","unstructured":"Secombe KR et al (2020) Diarrhea induced by small molecule tyrosine kinase inhibitors compared with chemotherapy: potential role of the microbiome. Integr Cancer Ther 19:1534735420928493","journal-title":"Integr Cancer Ther"},{"issue":"10","key":"8752_CR40","doi-asserted-by":"publisher","first-page":"633 e1","DOI":"10.1016\/j.jtct.2023.06.016","volume":"29","author":"SP Wong","year":"2023","unstructured":"Wong SP et al (2023) Oral and gut microbiota dysbiosis is associated with mucositis severity in autologous hematopoietic stem cell transplantation: evidence from an Asian population. Transplant Cell Ther 29(10):633 e1-633 e13","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"8752_CR41","doi-asserted-by":"publisher","first-page":"e1000879","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet MJ et al (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6(5):e1000879","journal-title":"PLoS Pathog"},{"issue":"1","key":"8752_CR42","doi-asserted-by":"publisher","first-page":"22911","DOI":"10.1038\/s41598-021-02308-w","volume":"11","author":"AR da Silva Ferreira","year":"2021","unstructured":"da Silva Ferreira AR et al (2021) Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy. Sci Rep 11(1):22911","journal-title":"Sci Rep"},{"issue":"7","key":"8752_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11745-012-3680-3","volume":"47","author":"TM Ferreira","year":"2012","unstructured":"Ferreira TM et al (2012) Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-Fluorouracil administration. Lipids 47(7):669\u2013678","journal-title":"Lipids"},{"issue":"10","key":"8752_CR44","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41564-022-01226-5","volume":"7","author":"P Spanogiannopoulos","year":"2022","unstructured":"Spanogiannopoulos P et al (2022) Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat Microbiol 7(10):1605\u20131620","journal-title":"Nat Microbiol"},{"issue":"7","key":"8752_CR45","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cell.2016.11.046","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M et al (2016) Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167(7):1897","journal-title":"Cell"},{"issue":"12","key":"8752_CR46","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/annonc\/mdz224","volume":"30","author":"N Chaput","year":"2019","unstructured":"Chaput N et al (2019) Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol 30(12):2012","journal-title":"Ann Oncol"},{"key":"8752_CR47","doi-asserted-by":"publisher","first-page":"1001623","DOI":"10.3389\/fimmu.2022.1001623","volume":"13","author":"G Zhou","year":"2022","unstructured":"Zhou G et al (2022) Interaction between gut microbiota and immune checkpoint inhibitor-related colitis. Front Immunol 13:1001623","journal-title":"Front Immunol"},{"issue":"11","key":"8752_CR48","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1007\/s00520-020-05579-7","volume":"28","author":"HR Wardill","year":"2020","unstructured":"Wardill HR et al (2020) Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer 28(11):5059\u20135073","journal-title":"Support Care Cancer"},{"key":"8752_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejca.2021.05.015","volume":"153","author":"HR Wardill","year":"2021","unstructured":"Wardill HR et al (2021) Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation. Eur J Cancer 153:27\u201339","journal-title":"Eur J Cancer"},{"issue":"4","key":"8752_CR50","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ijrobp.2022.03.036","volume":"113","author":"G Al-Qadami","year":"2022","unstructured":"Al-Qadami G et al (2022) Antibiotic-induced gut microbiota depletion accelerates the recovery of radiation-induced oral mucositis in rats. Int J Radiat Oncol Biol Phys 113(4):845\u2013858","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8752_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1078-0432.CCR-22-1254","volume":"29","author":"R Shouval","year":"2023","unstructured":"Shouval R et al (2023) Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation. Clin Cancer Res 29(1):165\u2013173","journal-title":"Clin Cancer Res"},{"key":"8752_CR52","doi-asserted-by":"publisher","first-page":"106488","DOI":"10.1016\/j.oraloncology.2023.106488","volume":"144","author":"A Fernandez Forne","year":"2023","unstructured":"Fernandez Forne A et al (2023) Influence of the microbiome on radiotherapy-induced oral mucositis and its management: a comprehensive review. Oral Oncol 144:106488","journal-title":"Oral Oncol"},{"issue":"1","key":"8752_CR53","doi-asserted-by":"publisher","first-page":"17527","DOI":"10.1038\/s41598-022-21775-3","volume":"12","author":"JS Bruno","year":"2022","unstructured":"Bruno JS et al (2022) Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients. Sci Rep 12(1):17527","journal-title":"Sci Rep"},{"issue":"4","key":"8752_CR54","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/microorganisms10040734","volume":"10","author":"A Laheij","year":"2022","unstructured":"Laheij A et al (2022) Long-term analysis of resilience of the oral microbiome in allogeneic stem cell transplant recipients. Microorganisms 10(4):734","journal-title":"Microorganisms"},{"issue":"1","key":"8752_CR55","doi-asserted-by":"publisher","first-page":"16929","DOI":"10.1038\/s41598-019-53073-w","volume":"9","author":"A Laheij","year":"2019","unstructured":"Laheij A et al (2019) Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep 9(1):16929","journal-title":"Sci Rep"},{"issue":"10","key":"8752_CR56","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.3390\/s121013002","volume":"12","author":"JA Covington","year":"2012","unstructured":"Covington JA et al (2012) The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study. Sensors (Basel) 12(10):13002\u201313018","journal-title":"Sensors (Basel)"},{"issue":"5","key":"8752_CR57","doi-asserted-by":"publisher","first-page":"e0126312","DOI":"10.1371\/journal.pone.0126312","volume":"10","author":"A Wang","year":"2015","unstructured":"Wang A et al (2015) Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS ONE 10(5):e0126312","journal-title":"PLoS ONE"},{"issue":"1","key":"8752_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13014-021-01899-y","volume":"16","author":"L Wang","year":"2021","unstructured":"Wang L et al (2021) The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review. Radiat Oncol 16(1):187","journal-title":"Radiat Oncol"},{"issue":"1","key":"8752_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00280-007-0570-0","volume":"62","author":"RM Logan","year":"2008","unstructured":"Logan RM et al (2008) Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 62(1):33\u201341","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"8752_CR60","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4161\/cbt.7.7.6207","volume":"7","author":"RM Logan","year":"2008","unstructured":"Logan RM et al (2008) Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7(7):1139\u20131145","journal-title":"Cancer Biol Ther"},{"key":"8752_CR61","doi-asserted-by":"publisher","first-page":"881949","DOI":"10.3389\/froh.2022.881949","volume":"3","author":"G Al-Qadami","year":"2022","unstructured":"Al-Qadami G et al (2022) Oral-gut microbiome axis in the pathogenesis of cancer treatment-induced oral mucositis. Front Oral Health 3:881949","journal-title":"Front Oral Health"},{"issue":"3","key":"8752_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/00365549109024323","volume":"23","author":"OJ Bergmann","year":"1991","unstructured":"Bergmann OJ (1991) Alterations in oral microflora and pathogenesis of acute oral infections during remission-induction therapy in patients with acute myeloid leukaemia. Scand J Infect Dis 23(3):355\u2013366","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"8752_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00280-017-3364-z","volume":"80","author":"RA Forsgard","year":"2017","unstructured":"Forsgard RA et al (2017) Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats. Cancer Chemother Pharmacol 80(2):317\u2013332","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"8752_CR64","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40168-019-0679-5","volume":"7","author":"BY Hong","year":"2019","unstructured":"Hong BY et al (2019) Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome 7(1):66","journal-title":"Microbiome"},{"issue":"1","key":"8752_CR65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.radonc.2018.04.023","volume":"129","author":"J Hou","year":"2018","unstructured":"Hou J et al (2018) Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy. Radiother Oncol 129(1):44\u201351","journal-title":"Radiother Oncol"},{"key":"8752_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2015.01.004","volume":"33","author":"YS Kim","year":"2015","unstructured":"Kim YS, Kim J, Park SJ (2015) High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. Anaerobe 33:1\u20137","journal-title":"Anaerobe"},{"key":"8752_CR67","doi-asserted-by":"publisher","first-page":"949071","DOI":"10.3389\/fonc.2022.949071","volume":"12","author":"I Klymiuk","year":"2022","unstructured":"Klymiuk I et al (2022) Chemotherapy-associated oral microbiome changes in breast cancer patients. Front Oncol 12:949071","journal-title":"Front Oncol"},{"issue":"5","key":"8752_CR68","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier E et al (2015) Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 42(5):515\u2013528","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"8752_CR69","doi-asserted-by":"publisher","first-page":"1761135","DOI":"10.1080\/20002297.2020.1761135","volume":"12","author":"JC Mougeot","year":"2020","unstructured":"Mougeot JC et al (2020) Lasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy. J Oral Microbiol 12(1):1761135","journal-title":"J Oral Microbiol"},{"issue":"21","key":"8752_CR70","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","volume":"25","author":"M Reis Ferreira","year":"2019","unstructured":"Reis Ferreira M et al (2019) Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy. Clin Cancer Res 25(21):6487\u20136500","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8752_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12282-020-01133-9","volume":"28","author":"KR Secombe","year":"2021","unstructured":"Secombe KR et al (2021) Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant. Breast Cancer 28(1):99\u2013109","journal-title":"Breast Cancer"},{"issue":"7","key":"8752_CR72","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00520-013-1741-7","volume":"21","author":"AM Stringer","year":"2013","unstructured":"Stringer AM et al (2013) Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 21(7):1843\u20131852","journal-title":"Support Care Cancer"},{"issue":"12","key":"8752_CR73","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","volume":"7","author":"AM Stringer","year":"2008","unstructured":"Stringer AM et al (2008) Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther 7(12):1919\u20131925","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"8752_CR74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/599346","volume":"49","author":"MJ van Vliet","year":"2009","unstructured":"van Vliet MJ et al (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2):262\u2013270","journal-title":"Clin Infect Dis"},{"issue":"2","key":"8752_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00280-021-04273-7","volume":"88","author":"HR Wardill","year":"2021","unstructured":"Wardill HR et al (2021) Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever. Cancer Chemother Pharmacol 88(2):173\u2013188","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"8752_CR76","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ctrv.2014.11.005","volume":"41","author":"HR Wardill","year":"2015","unstructured":"Wardill HR et al (2015) Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity. Cancer Treat Rev 41(2):122\u2013128","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"8752_CR77","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-15-0990","volume":"15","author":"HR Wardill","year":"2016","unstructured":"Wardill HR et al (2016) Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Mol Cancer Ther 15(6):1376\u20131386","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"8752_CR78","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00280-013-2238-2","volume":"72","author":"K Hamada","year":"2013","unstructured":"Hamada K et al (2013) Disruption of ZO-1\/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis. Cancer Chemother Pharmacol 72(4):757\u2013765","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"8752_CR79","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-16-0330","volume":"15","author":"HR Wardill","year":"2016","unstructured":"Wardill HR et al (2016) TLR4-dependent Claudin-1 internalization and secretagogue-mediated chloride secretion regulate irinotecan-induced diarrhea. Mol Cancer Ther 15(11):2767\u20132779","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"8752_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00280-018-3605-9","volume":"82","author":"S Khan","year":"2018","unstructured":"Khan S, Wardill HR, Bowen JM (2018) Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis. Cancer Chemother Pharmacol 82(1):31\u201337","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"8752_CR81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00280-021-04382-3","volume":"89","author":"KR Secombe","year":"2022","unstructured":"Secombe KR et al (2022) Intestinal toll-like receptor 4 knockout alters the functional capacity of the gut microbiome following irinotecan treatment. Cancer Chemother Pharmacol 89(2):275\u2013281","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"8752_CR82","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/jcp.29976","volume":"236","author":"EE Bruning","year":"2021","unstructured":"Bruning EE et al (2021) Site-specific contribution of Toll-like receptor 4 to intestinal homeostasis and inflammatory disease. J Cell Physiol 236(2):877\u2013888","journal-title":"J Cell Physiol"},{"key":"8752_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.toxlet.2019.08.012","volume":"315","author":"YJ Shi","year":"2019","unstructured":"Shi YJ et al (2019) Critical role of toll-like receptor 4 (TLR4) in dextran sulfate sodium (DSS)-Induced intestinal injury and repair. Toxicol Lett 315:23\u201330","journal-title":"Toxicol Lett"},{"key":"8752_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1743-7075-11-17","volume":"11","author":"I Sukhotnik","year":"2014","unstructured":"Sukhotnik I et al (2014) Glutamine attenuates the inhibitory effect of methotrexate on TLR signaling during intestinal chemotherapy-induced mucositis in a rat. Nutr Metab (Lond) 11:17","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"8752_CR85","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.4049\/jimmunol.1402481","volume":"194","author":"M Frank","year":"2015","unstructured":"Frank M et al (2015) TLR signaling modulates side effects of anticancer therapy in the small intestine. J Immunol 194(4):1983\u20131995","journal-title":"J Immunol"},{"issue":"5873","key":"8752_CR86","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1126\/science.1154986","volume":"320","author":"LG Burdelya","year":"2008","unstructured":"Burdelya LG et al (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320(5873):226\u2013230","journal-title":"Science"},{"issue":"1","key":"8752_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijrobp.2011.05.055","volume":"83","author":"LG Burdelya","year":"2012","unstructured":"Burdelya LG et al (2012) Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys 83(1):228\u2013234","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"8752_CR88","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00280-016-3139-y","volume":"78","author":"RA Ribeiro","year":"2016","unstructured":"Ribeiro RA et al (2016) Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemother Pharmacol 78(5):881\u2013893","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"8752_CR89","first-page":"3508","volume":"10","author":"T Tian","year":"2020","unstructured":"Tian T et al (2020) The protective role of short-chain fatty acids acting as signal molecules in chemotherapy-or radiation-induced intestinal inflammation. Am J Cancer Res 10(11):3508","journal-title":"Am J Cancer Res"},{"key":"8752_CR90","doi-asserted-by":"publisher","first-page":"113163","DOI":"10.1016\/j.biopha.2022.113163","volume":"151","author":"C Panebianco","year":"2022","unstructured":"Panebianco C et al (2022) Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models. Biomed Pharmacother 151:113163","journal-title":"Biomed Pharmacother"},{"key":"8752_CR91","doi-asserted-by":"publisher","first-page":"113528","DOI":"10.1016\/j.biopha.2022.113528","volume":"153","author":"C Cristiano","year":"2022","unstructured":"Cristiano C et al (2022) Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction. Biomed Pharmacother 153:113528","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"8752_CR92","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1017\/S0007114520004924","volume":"126","author":"B Gallotti","year":"2021","unstructured":"Gallotti B et al (2021) Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model. Br J Nutr 126(6):853\u2013864","journal-title":"Br J Nutr"},{"issue":"18","key":"8752_CR93","doi-asserted-by":"publisher","first-page":"e2100222","DOI":"10.1002\/mnfr.202100222","volume":"65","author":"M Beukema","year":"2021","unstructured":"Beukema M et al (2021) Attenuation of doxorubicin-induced small intestinal mucositis by pectins is dependent on pectin\u2019s methyl-ester number and distribution. Mol Nutr Food Res 65(18):e2100222","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"8752_CR94","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/s41598-020-73292-w","volume":"10","author":"N Gupta","year":"2020","unstructured":"Gupta N et al (2020) Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis. Sci Rep 10(1):16189","journal-title":"Sci Rep"},{"key":"8752_CR95","doi-asserted-by":"publisher","first-page":"684824","DOI":"10.3389\/fimmu.2021.684824","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Probiotic Streptococcus salivarius K12 alleviates radiation-induced oral mucositis in mice. Front Immunol 12:684824","journal-title":"Front Immunol"},{"issue":"12","key":"8752_CR96","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1200\/JCO.23.00837","volume":"42","author":"X Peng","year":"2024","unstructured":"Peng X et al (2024) Streptococcus salivarius K12 alleviates oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors: a randomized controlled trial. J Clin Oncol 42(12):1426\u20131435","journal-title":"J Clin Oncol"},{"issue":"12","key":"8752_CR97","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1200\/JCO.23.02706","volume":"42","author":"HR Wardill","year":"2024","unstructured":"Wardill HR, Bossi P, Sonis ST (2024) Understanding protective mechanisms of an oral probiotic in reducing radiation-induced oral mucositis. J Clin Oncol 42(12):1436\u20131438","journal-title":"J Clin Oncol"},{"issue":"2","key":"8752_CR98","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SPC.0000000000000338","volume":"12","author":"HR Wardill","year":"2018","unstructured":"Wardill HR et al (2018) Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis. Curr Opin Support Palliat Care 12(2):187\u2013197","journal-title":"Curr Opin Support Palliat Care"},{"key":"8752_CR99","doi-asserted-by":"publisher","first-page":"200148","DOI":"10.1016\/j.hnm.2022.200148","volume":"28","author":"RL Washburn","year":"2022","unstructured":"Washburn RL, Sandberg D, Stofer MAG (2022) Supplementation of a single species probiotic does not affect diversity and composition of the healthy adult gastrointestinal microbiome. Hum Nutr Metab 28:200148","journal-title":"Hum Nutr Metab"},{"key":"8752_CR100","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","volume":"44","author":"HR Wardill","year":"2019","unstructured":"Wardill HR et al (2019) Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine 44:730\u2013740","journal-title":"EBioMedicine"},{"key":"8752_CR101","doi-asserted-by":"publisher","first-page":"109829","DOI":"10.1016\/j.biopha.2020.109829","volume":"124","author":"H Chen","year":"2020","unstructured":"Chen H et al (2020) Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Biomed Pharmacother 124:109829","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8752_CR102","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1038\/s41598-018-24342-x","volume":"8","author":"Q Le Bastard","year":"2018","unstructured":"Le Bastard Q et al (2018) Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice. Sci Rep 8(1):6219","journal-title":"Sci Rep"},{"key":"8752_CR103","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1016\/j.csbj.2021.10.028","volume":"19","author":"H Xiao","year":"2021","unstructured":"Xiao H et al (2021) Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice. Comput Struct Biotechnol J 19:5898\u20135910","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"8752_CR104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W (2018) Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 15(2):111\u2013128","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"8752_CR105","doi-asserted-by":"publisher","first-page":"e0156334","DOI":"10.1371\/journal.pone.0156334","volume":"11","author":"JH Park","year":"2016","unstructured":"Park JH et al (2016) Promotion of intestinal epithelial cell turnover by commensal bacteria: role of Short-Chain Fatty Acids. PLoS ONE 11(5):e0156334","journal-title":"PLoS ONE"},{"issue":"10","key":"8752_CR106","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/ijms17101696","volume":"17","author":"W Miao","year":"2016","unstructured":"Miao W et al (2016) Sodium butyrate promotes reassembly of tight junctions in Caco-2 monolayers involving inhibition of MLCK\/MLC2 pathway and phosphorylation of PKCbeta2. Int J Mol Sci 17(10):1696","journal-title":"Int J Mol Sci"},{"issue":"9","key":"8752_CR107","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L et al (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139(9):1619\u20131625","journal-title":"J Nutr"},{"key":"8752_CR108","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fmed.2020.00421","volume":"7","author":"J Ouyang","year":"2020","unstructured":"Ouyang J et al (2020) Treating from the inside out: relevance of fecal microbiota transplantation to counteract gut damage in GVHD and HIV infection. Front Med (Lausanne) 7:421","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 4","key":"8752_CR109","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2527\/jas.50965","volume":"90","author":"X Ma","year":"2012","unstructured":"Ma X et al (2012) Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions. J Anim Sci 90(Suppl 4):266\u2013268","journal-title":"J Anim Sci"},{"key":"8752_CR110","doi-asserted-by":"publisher","first-page":"27543","DOI":"10.3402\/jom.v7.27543","volume":"7","author":"AM Laheij","year":"2015","unstructured":"Laheij AM et al (2015) The impact of virulence factors of Porphyromonas gingivalis on wound healing in vitro. J Oral Microbiol 7:27543","journal-title":"J Oral Microbiol"},{"issue":"1","key":"8752_CR111","doi-asserted-by":"publisher","first-page":"1328266","DOI":"10.1080\/20002297.2017.1328266","volume":"9","author":"TM Haverman","year":"2017","unstructured":"Haverman TM et al (2017) Candida and Porphyromonas gingivalis: the effect on wound closure in vitro. J Oral Microbiol 9(1):1328266","journal-title":"J Oral Microbiol"},{"issue":"10","key":"8752_CR112","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1007\/s00520-020-05318-y","volume":"28","author":"TM Haverman","year":"2020","unstructured":"Haverman TM et al (2020) Exploring the role of oral microorganisms in the pathogenesis of mucositis by assessing their impact on metabolic activity and reproductive capacity of epithelial cells in vitro. Support Care Cancer 28(10):4729\u20134735","journal-title":"Support Care Cancer"},{"issue":"4","key":"8752_CR113","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1535370217753842","volume":"243","author":"E Vanlancker","year":"2018","unstructured":"Vanlancker E et al (2018) Oral microbiota reduce wound healing capacity of epithelial monolayers, irrespective of the presence of 5-fluorouracil. Exp Biol Med (Maywood) 243(4):350\u2013360","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"8752_CR114","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"LY Zhao","year":"2023","unstructured":"Zhao LY et al (2023) Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther 8(1):201","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"8752_CR115","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","volume":"164","author":"D Chrysostomou","year":"2023","unstructured":"Chrysostomou D et al (2023) Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy. Gastroenterology 164(2):198\u2013213","journal-title":"Gastroenterology"},{"issue":"19","key":"8752_CR116","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S et al (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126(19):4423\u20134431","journal-title":"Cancer"},{"issue":"1","key":"8752_CR117","doi-asserted-by":"publisher","first-page":"1979878","DOI":"10.1080\/19490976.2021.1979878","volume":"13","author":"KR Secombe","year":"2021","unstructured":"Secombe KR et al (2021) Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols. Gut Microbes 13(1):1979878","journal-title":"Gut Microbes"},{"issue":"11","key":"8752_CR118","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi C et al (2021) Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med 27(11):1885\u20131892","journal-title":"Nat Med"},{"issue":"7","key":"8752_CR119","doi-asserted-by":"publisher","first-page":"e1002606","DOI":"10.1371\/journal.pcbi.1002606","volume":"8","author":"K Faust","year":"2012","unstructured":"Faust K et al (2012) Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 8(7):e1002606","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"8752_CR120","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/prd.12359","volume":"85","author":"E Zaura","year":"2021","unstructured":"Zaura E et al (2021) Optimizing the quality of clinical studies on oral microbiome: a practical guide for planning, performing, and reporting. Periodontol 2000 85(1):210\u2013236","journal-title":"Periodontol 2000"},{"issue":"2","key":"8752_CR121","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1055-9965.EPI-16-0538","volume":"26","author":"G Yu","year":"2017","unstructured":"Yu G et al (2017) Evaluation of buccal cell samples for studies of oral microbiota. Cancer Epidemiol Biomarkers Prev 26(2):249\u2013253","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8752_CR122","doi-asserted-by":"publisher","first-page":"175883591882102","DOI":"10.1177\/1758835918821021","volume":"11","author":"CH Wu","year":"2019","unstructured":"Wu CH et al (2019) D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation. Ther Adv Med Oncol 11:1758835918821021","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"8752_CR123","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4014\/jmb.2110.10018","volume":"32","author":"L Deng","year":"2022","unstructured":"Deng L et al (2022) Simotang alleviates the gastrointestinal side effects of chemotherapy by altering gut microbiota. J Microbiol Biotechnol 32(4):405\u2013418","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"8752_CR124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/biom11010034","volume":"11","author":"AR da Silva Ferreira","year":"2020","unstructured":"da Silva Ferreira AR et al (2020) Prophylactic treatment with vitamins C and B2 for methotrexate-induced gastrointestinal mucositis. Biomolecules 11(1):34","journal-title":"Biomolecules"},{"issue":"1","key":"8752_CR125","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12602-021-09795-3","volume":"14","author":"W Yuan","year":"2022","unstructured":"Yuan W et al (2022) Probiotic therapy (BIO-THREE) mitigates intestinal microbial imbalance and intestinal damage caused by oxaliplatin. Probiotics Antimicrob Proteins 14(1):60\u201371","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"6","key":"8752_CR126","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.21037\/apm-20-2183","volume":"9","author":"M Zhang","year":"2020","unstructured":"Zhang M et al (2020) The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy. Ann Palliat Med 9(6):4211\u20134227","journal-title":"Ann Palliat Med"},{"issue":"4","key":"8752_CR127","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00186-19","volume":"4","author":"JJ Minich","year":"2019","unstructured":"Minich JJ et al (2019) Quantifying and understanding well-to-well contamination in microbiome research. mSystems 4(4):10\u20131128","journal-title":"mSystems"},{"issue":"7","key":"8752_CR128","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R et al (2018) Best practices for analysing microbiomes. Nat Rev Microbiol 16(7):410\u2013422","journal-title":"Nat Rev Microbiol"},{"key":"8752_CR129","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbi.2023.09.022","volume":"115","author":"AJ McGuinness","year":"2023","unstructured":"McGuinness AJ et al (2023) From hype to hope: considerations in conducting robust microbiome science. Brain Behav Immun 115:120\u2013130","journal-title":"Brain Behav Immun"},{"issue":"1","key":"8752_CR130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00127-16","volume":"2","author":"AM Comeau","year":"2017","unstructured":"Comeau AM, Douglas GM, Langille MG (2017) Microbiome helper: a custom and streamlined workflow for microbiome research. mSystems 2(1):10\u20131128","journal-title":"mSystems"},{"key":"8752_CR131","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4939-8728-3_9","volume":"1849","author":"GM Douglas","year":"2018","unstructured":"Douglas GM, Comeau AM, Langille MGI (2018) Processing a 16S rRNA sequencing dataset with the microbiome helper workflow. Methods Mol Biol 1849:131\u2013141","journal-title":"Methods Mol Biol"},{"key":"8752_CR132","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.csbj.2023.03.030","volume":"21","author":"B Xiang","year":"2023","unstructured":"Xiang B, Zhao L, Zhang M (2023) Unitig level assembly graph based metagenome-assembled genome refiner (UGMAGrefiner): A tool to increase completeness and resolution of metagenome-assembled genomes. Comput Struct Biotechnol J 21:2394\u20132404","journal-title":"Comput Struct Biotechnol J"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08752-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08752-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:10:55Z","timestamp":1723612255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08752-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8752"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08752-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"558"}}